Castellan Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,276
| Closed | -$3.49M | – | 67 |
|
|
2024
Q3 | $3.49M | Sell |
29,276
-13,195
| -31% | -$1.57M | 1.47% | 30 |
|
|
2024
Q2 | $6.06M | Buy |
42,471
+2,162
| +5% | +$309K | 2.89% | 8 |
|
|
2024
Q1 | $5.18M | Sell |
40,309
-3,598
| -8% | -$462K | 2.65% | 14 |
|
|
2023
Q4 | $4.54M | Buy |
43,907
+3,032
| +7% | +$314K | 2.82% | 6 |
|
|
2023
Q3 | $3.72M | Sell |
40,875
-3,873
| -9% | -$352K | 2.61% | 7 |
|
|
2023
Q2 | $3.62M | Sell |
44,748
-6,782
| -13% | -$549K | 2.31% | 11 |
|
|
2023
Q1 | $4.1M | Sell |
51,530
-4,520
| -8% | -$360K | 2.8% | 7 |
|
|
2022
Q4 | $3.79M | Sell |
56,050
-610
| -1% | -$41.3K | 2.64% | 8 |
|
|
2022
Q3 | $2.82M | Sell |
56,660
-4,570
| -7% | -$228K | 2.19% | 19 |
|
|
2022
Q2 | $3.41M | Sell |
61,230
-2,620
| -4% | -$146K | 2.7% | 8 |
|
|
2022
Q1 | $3.55M | Buy |
63,850
+6,610
| +12% | +$367K | 2.46% | 9 |
|
|
2021
Q4 | $3.21M | Buy |
57,240
+13,400
| +31% | +$750K | 2.22% | 7 |
|
|
2021
Q3 | $2.11M | Buy |
+43,840
| New | +$2.11M | 1.08% | 31 |
|